FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:2018-2019 December 23, 1999 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Drolet, B. A. PubMed Citation

To the Editor: In their otherwise thoughtful and informative article, Drolet and colleagues (July 15 issue)¹ dismiss intralesional corticosteroid injection in the treatment of juvenile periocular hemangiomas as "contraindicated, since it is fraught with complications." I am surprised at this statement, since I believe that intralesional corticosteroids are considered the treatment of choice by a large number of pediatric ophthalmologists and oculoplastic surgeons.^2,3,4,5

The statement "fraught with complications" is misleading because it implies a high frequency of complications. However, the authors cite only several case reports of complications; no incidence is given. In fact, serious complications occur infrequently with this . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Sundine, M. J., Wirth, G. A. (2007). Hemangiomas: An Overview. CLIN PEDIATR 46: 206-221  
• Egbert, J. E., Paul, S., Engel, W. K., Summers, C. G. (2001). High Injection Pressure During Intralesional Injection of Corticosteroids Into Capillary Hemangiomas. Arch Ophthalmol 119: 677-683 [Abstract] [Full Text]  
• (2000). Hemangiomas. Arch Ophthalmol 118: 835-836 [Full Text]